Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-25-056440

Interim CEO & General Counsel gave up 22,127 shares (to pay taxes)

  • Interim CEO & General Counsel acquired 52,085 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Vogt Frederick G Interim CEO & General Counsel 2025-06-02 Option exercise +52,085 426,731 D: show line 1 in the form
Vogt Frederick G Interim CEO & General Counsel 2025-06-02 Shares withheld for taxes −22,127 $1.76 $38,944 404,604 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Vogt Frederick G Interim CEO & General Counsel 2025-06-02 Option exercise · Restricted Stock Units −10,417 31,252 D: show line 3 in the form
Vogt Frederick G Interim CEO & General Counsel 2025-06-02 Option exercise · Restricted Stock Units −41,668 291,682 D: show line 4 in the form
Loading xslF345X05/tm2517077-4_4seq1.xml…